Boralex stock is in focus on March 26 after reports that CDPQ and Brookfield submitted an offer to acquire the company. Shares of Boralex (BLX.TO) recently traded around C$36.62, near a 52-week high, as investors weigh a potential control premium and sector consolidation. La Presse reported the approach, and the CEO discussed it with Radio-Canada. We break down what this could mean for Boralex stock, how the chart looks after the spike, and which catalysts Canadian investors should watch next.
CDPQ and Brookfield bid: what we know
La Presse reported that CDPQ and Brookfield offered to acquire Boralex, citing sources familiar with the talks. Management acknowledged the approach, and the CEO discussed it with Radio-Canada. No terms were disclosed, and the board has not announced a recommendation. For confirmation, see La Presse and Radio-Canada. Until a formal bid appears, Boralex stock will trade on expectations.
If a formal proposal arrives, investors often look for a premium over the recent close to reflect control and the growth pipeline. The board would likely form an independent committee, assess valuation, and review financing certainty and regulatory risk. Any agreement might include go-shop or break fees. Deal certainty and timing will drive Boralex stock near term, not standalone fundamentals.
Market reaction and technical setup
Boralex stock trades near C$36.62 with an intraday range of C$36.55 to C$36.67, brushing a 52-week high of C$36.65. Volume spiked to 2,897,498 versus a 490,305 average, confirming interest. RSI is 87.89 and MFI 89.77, both overbought. ADX at 34.84 signals a strong trend, while MACD histogram at 0.95 stays positive. Momentum is up, but overbought readings flag near-term risk.
Immediate resistance sits near C$36.67. First support tracks the Bollinger middle band at C$28.93 and Keltner middle at C$29.88. ATR at 1.21 suggests wide daily swings. If headlines pause, mean reversion is possible. Traders in Boralex stock may consider tight risk controls, while longer-term holders can watch if price bases above C$33 to C$30 on lighter volume.
Valuation, leverage, and cash flows
On fundamentals, Boralex stock screens rich: TTM P/E about 563.1, EV/EBITDA near 15.67, and price-to-sales around 4.49. Dividend yield is roughly 1.80% with a 0.66 per-share payout. Free cash flow per share is negative at -2.43, reflecting heavy growth capex. The setup favors bidders with lower capital costs since funding the pipeline is resource intensive.
Leverage is high, with debt-to-equity at 3.23x and net debt to EBITDA near 8.66x. Interest coverage stands around 1.01x, showing tight headroom. Rising or sticky rates can pressure valuation and refinancing. A buyer with cheaper financing could create value by lowering the weighted average cost of capital, which the board will factor when evaluating any offer.
Catalysts, scenarios, and investor playbook
If the board deems the approach credible, expect an independent committee, due diligence, and negotiation on price, terms, and financing. Any deal would face approvals, including Competition Bureau review and other Canadian regulatory checks. Earnings on May 13, 2026, offer a near-term update on operations and guidance. New bids or a revised proposal could reset expectations for Boralex stock.
Event paths range from a firm offer to talks ending. Holders may keep a core position while trimming into strength to manage gap risk. Short-term traders can wait for pullbacks toward support with defined stops. Without a deal, valuation and leverage could reassert. Size positions prudently given headline risk and a 1.21 ATR profile.
Final Thoughts
For Canadian investors, the CDPQ and Brookfield approach adds a clear event driver to an already strong tape. Boralex stock now trades near a 52-week high with overbought momentum and heavy volume, which raises both opportunity and risk. We would watch for a formal bid, board updates, and any competing interest. The valuation is demanding and leverage is elevated, so deal certainty and financing terms matter. Traders can stay nimble with tight stops around recent highs and the C$33 to C$30 area. Long-term investors can focus on whether price holds above key moving averages while monitoring May 13 earnings for project updates. Until clarity arrives, news flow likely dominates price action.
FAQs
What is driving Boralex stock today?
Reports that CDPQ and Brookfield made an offer to acquire Boralex are driving attention and volume. Shares trade near C$36.62 and a 52-week high, with RSI at 87.89 showing overbought momentum. Until a formal proposal is filed, headlines, board updates, and any rival interest will likely guide short-term price moves.
Is Boralex stock expensive on fundamentals?
Yes. The stock trades at a TTM P/E near 563 and EV/EBITDA around 15.7, with price-to-sales about 4.5. Free cash flow per share is negative due to heavy capex, and leverage is high. A strategic buyer with lower financing costs could justify the premium, but standalone metrics suggest limited value room without growth.
What key price levels should I watch?
Near-term resistance is around C$36.67. On pullbacks, watch the Bollinger middle band near C$28.93 and the Keltner middle near C$29.88 as potential support zones. With ATR at 1.21, daily swings can be wide. If price consolidates above C$33 to C$30 on lighter volume, the setup looks healthier.
What milestones could move the stock next?
Potential catalysts include a formal bid, a board recommendation, or competing offers. Regulatory clarity would also help. Operationally, earnings on May 13, 2026, can update investors on assets, cash flow, and guidance. Any shift in rates or power prices could also influence valuation and the appetite of potential buyers.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)